RT Journal Article
SR Electronic
T1 Evaluation of Urine SARS-COV-2 RT-PCR as a predictor of Acute Kidney Injury and disease severity in critical COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.13.21249576
DO 10.1101/2021.01.13.21249576
A1 de Souza, Sérgio Pinto
A1 Silveira, Marcelo Augusto Duarte
A1 de Freitas Souza, Bruno Solano
A1 Nonaka, Carolina Kymie Vasques
A1 de Melo, Erica
A1 Cabral, Julia
A1 Coelho, Fernanda
A1 da Hora Passos, Rogério
YR 2021
UL http://medrxiv.org/content/early/2021/01/15/2021.01.13.21249576.abstract
AB The novel coronavirus disease (COVID-19) is an emerging infectious disease caused by SARS-CoV-2, which began as an outbreak in Wuhan, China and spread rapidly throughout the globe. Although the majority of infections are mild, severe and critical COVID-19 patients face deterioration of respiratory function, and may also present extrapulmonary manifestations, mostly affecting the kidney, digestive tract, heart and nervous system. Here, we prospectively evaluated the presence of SARS-CoV-2 genetic material by RT-PCR in urine samples obtained from critical care COVID-19 patients. In 51 patients included, we found higher serum creatinine levels, a longer hospital stay and a more frequent dialysis need in urine-positive patients. These findings could suggest that, in predisposed patients, a direct viral cytopathic effect may contribute to a more severe disease phenotype.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe had no funding support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted following the principles of the Declaration of Helsinki and received prior approval by the Ethics Committee of Sao Rafael Hospital in Salvador, Brazil (CAAE 34428920.0.0000.0048). All participants gave informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referring to the manuscript are available.